Defining Moments Following the Science: The Origin Story of a New Therapeutic Approach in HAE Championing an investigational medicine to make a meaningful difference in the lives of those living with HAE Image
Defining Moments Defining the Future of RNA Medicines Ionis CEO Brett Monia, Ph.D. shares the journey to becoming a fully integrated biotech, advancing RNA-targeted medicines and delivering greater impact for patients. Image
